Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option

REDWOOD CITY, Calif., July 24, 2019 (GLOBE NEWSWIRE) — Rezolute, Inc. (“Rezolute”) (OTCQB:RZLT), a clinical stage biopharmaceutical company specializing in the development of transformative therapies targeting metabolic and orphan diseases, announced today that Handok, Inc. (“Handok”) and Genexine, Inc. (“Genexine”), exercised their combined full $20 million option to purchase shares of Rezolute common stock, increasing their […]

Afya Limited Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

NOVA LIMA, Brazil, July 23, 2019 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA) today announced the closing of its initial public offering of 15,805,841 Class A common shares at a public offering price of $19.00 per share. Afya issued and sold 13,888,887 shares of Class A common shares, which includes the full exercise […]